ES8207184A1 - Procedimiento para la preparacion de composiciones fosfoli- pidicas de colina - Google Patents

Procedimiento para la preparacion de composiciones fosfoli- pidicas de colina

Info

Publication number
ES8207184A1
ES8207184A1 ES502080A ES502080A ES8207184A1 ES 8207184 A1 ES8207184 A1 ES 8207184A1 ES 502080 A ES502080 A ES 502080A ES 502080 A ES502080 A ES 502080A ES 8207184 A1 ES8207184 A1 ES 8207184A1
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
oral administration
administration containing
containing cytidine
cytidine diphosphocholine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES502080A
Other languages
English (en)
Spanish (es)
Other versions
ES502080A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Made Italiana SRL
Original Assignee
Made Italiana SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Made Italiana SRL filed Critical Made Italiana SRL
Publication of ES502080A0 publication Critical patent/ES502080A0/es
Publication of ES8207184A1 publication Critical patent/ES8207184A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES502080A 1980-04-18 1981-04-15 Procedimiento para la preparacion de composiciones fosfoli- pidicas de colina Expired ES8207184A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8048454A IT1207106B (it) 1980-04-18 1980-04-18 Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale

Publications (2)

Publication Number Publication Date
ES502080A0 ES502080A0 (es) 1982-09-01
ES8207184A1 true ES8207184A1 (es) 1982-09-01

Family

ID=11266633

Family Applications (1)

Application Number Title Priority Date Filing Date
ES502080A Expired ES8207184A1 (es) 1980-04-18 1981-04-15 Procedimiento para la preparacion de composiciones fosfoli- pidicas de colina

Country Status (15)

Country Link
US (1) US4386077A (OSRAM)
AT (1) AT376366B (OSRAM)
AU (1) AU544469B2 (OSRAM)
BE (1) BE890796A (OSRAM)
CH (1) CH652026A5 (OSRAM)
DE (1) DE3115080C2 (OSRAM)
DK (1) DK173081A (OSRAM)
ES (1) ES8207184A1 (OSRAM)
FR (1) FR2480603B1 (OSRAM)
GB (1) GB2074445B (OSRAM)
IN (1) IN156105B (OSRAM)
IT (1) IT1207106B (OSRAM)
NL (1) NL8101899A (OSRAM)
SE (1) SE447449B (OSRAM)
ZA (1) ZA812600B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569929A (en) * 1980-02-29 1986-02-11 Massachusetts Institute Of Technology Cytidyl diphosphocholine-drug composition
EP0114577A1 (en) * 1983-01-21 1984-08-01 MAGIS FARMACEUTICI S.p.A. New pharmaceutical composition
IT1201474B (it) * 1985-10-01 1989-02-02 Vincenzo Zappia Derivati macromolecolarizzati di cdp-colina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5482706A (en) * 1992-04-17 1996-01-09 Takeda Chemical Industries, Ltd. Transmucosal therapeutic composition
ES2244968T3 (es) * 1995-03-06 2005-12-16 Interneuron Pharmaceuticals Incorporated Reduccion del volumen de infarto usando citocolina.
AU2005201251B2 (en) * 1995-03-06 2006-04-27 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
US5872108A (en) * 1995-03-06 1999-02-16 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU1640400A (en) * 1995-03-06 2000-04-20 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
US8030294B2 (en) * 2000-03-16 2011-10-04 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
CA2517290A1 (en) * 2003-02-26 2004-09-10 Kyowa Hakko Kogyo Co., Ltd. Muscle-building agent and preventive or remedy for muscle weakening
WO2005122767A1 (en) * 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
US20090215714A1 (en) * 2004-06-10 2009-08-27 Perry Renshaw Pyrimidines, such as cytidine, in treatments for patients with biopolar disorder
WO2006020703A1 (en) * 2004-08-11 2006-02-23 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666748A (en) * 1967-12-18 1972-05-30 Takeda Chemical Industries Ltd Method for production of cytidine (or deoxycytidine)-5{40 -diphosphate choline and intermediates therefor
NL149812B (nl) * 1969-04-24 1976-06-15 Takeda Chemical Industries Ltd Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van kristallijn cytidine-5'-difosfaat-choline-monohydraat.
JPS4841555B1 (OSRAM) * 1969-08-04 1973-12-07
JPS4886869A (OSRAM) * 1972-02-23 1973-11-15

Also Published As

Publication number Publication date
IN156105B (OSRAM) 1985-05-18
NL8101899A (nl) 1981-11-16
BE890796A (fr) 1982-02-15
AU544469B2 (en) 1985-05-30
ES502080A0 (es) 1982-09-01
AU6994581A (en) 1981-10-22
SE447449B (sv) 1986-11-17
FR2480603A1 (fr) 1981-10-23
DK173081A (da) 1981-10-19
GB2074445A (en) 1981-11-04
DE3115080A1 (de) 1982-02-25
ATA172081A (de) 1984-04-15
AT376366B (de) 1984-11-12
CH652026A5 (it) 1985-10-31
ZA812600B (en) 1982-04-28
IT1207106B (it) 1989-05-17
IT8048454A0 (it) 1980-04-18
GB2074445B (en) 1983-09-07
DE3115080C2 (de) 1986-10-16
US4386077A (en) 1983-05-31
SE8102456L (sv) 1981-10-19
FR2480603B1 (fr) 1985-07-12

Similar Documents

Publication Publication Date Title
ES8207184A1 (es) Procedimiento para la preparacion de composiciones fosfoli- pidicas de colina
SE8402550D0 (sv) N-substituerade deriavat av moranolin
ES537578A0 (es) Procedimiento para la estabilizacion de preparados farmaceuticos en forma de suspensiones conteniendo sucralfato
JO1552B1 (en) New pyridizinamine derivatives
DK0413171T3 (da) Middel til behandling af svære smertetilstande og fremgangsmåde til fremstilling heraf
ES2073164T3 (es) Liposomas heterovesiculares.
FI893022A0 (fi) Stabila preparat innehaollande fettloesliga aemnen och framstaellning daerav.
AR231972A1 (es) Derivados de n-(ariloil o heteroariloil)-n-fenil-urea,composiciones plaguicidas que los contienen y procedimiento para la preparacion de dichos derivados
ES2019590B3 (es) Productos con contenido fosfolipido, fabricacion de los mismos y empleo.
ES507807A0 (es) Procedimiento para la obtencion de derivados triciclicos de citosina.
NO169189C (no) Blanding paa basis av biopolymerer, fremgangsmaate for deres fremstilling og anvendelse av blandingen
DE2961609D1 (en) Sila-substituted 1,4-dihydropyridine derivatives, processes for their preparation, pharmaceutical compositions and process for their preparation
JPS56115793A (en) Phosphonohydroxyacetic acid* its salt* their manufacture and drug thereof as active component
FR2343730A1 (fr) Derives d'acide amidinoformique ou d'acide amidinosulfinique, leur preparation et compositions pharmaceutiques les contenant
SE8302580D0 (sv) Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning
MX9206806A (es) Pudines listos para tomar que contienen polifosfato
NO156900C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater.
GR68194B (OSRAM)
ES352646A1 (es) Un procedimiento para la preparacion de derivados benzodia-cepinicos.
IT1141606B (it) Derivati di 1 sostituiti 3 cicloalchil solfonil pirrolidin 2 5 dioni composizioni fungicide che li contengono e procedimento per la preparazione degli ingredienti attivi nonche delle composizioni
SE8001235L (sv) 2,2-dimetyl-1,2-dihydrokinolinderivat anvendbara som antioxidanter, jemte sett for deras framstellning och blandningar innehallande dem
FR2541276B1 (fr) Derives du dithiolane, leur preparation et compositions pharmaceutiques contenant ces derives
AR230276A1 (es) Derivados de 2,3-dihidro-2,2-dimetilbenzofuran-7-il-n-aminosulfenil-n-metil carbamato,composiciones insecticidas,acaricidas y nematocidas que los contienen y procedimiento para su preparacion
ES334300A1 (es) Un procedimiento para la preparacion de derivados de benzo-diacepina.
MX169075B (es) Composicion cosmetica para el cabello